RU96104560A - METHOD FOR PREPARING HUMAN ERYTHROPOIETIN AND METHOD FOR MAKING A PHARMACEUTICAL COMPOSITION - Google Patents
METHOD FOR PREPARING HUMAN ERYTHROPOIETIN AND METHOD FOR MAKING A PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- RU96104560A RU96104560A RU96104560/13A RU96104560A RU96104560A RU 96104560 A RU96104560 A RU 96104560A RU 96104560/13 A RU96104560/13 A RU 96104560/13A RU 96104560 A RU96104560 A RU 96104560A RU 96104560 A RU96104560 A RU 96104560A
- Authority
- RU
- Russia
- Prior art keywords
- erythropoietin
- cells
- dna
- human erythropoietin
- sequence
- Prior art date
Links
- 102000003951 Erythropoietin Human genes 0.000 title claims 27
- 108090000394 Erythropoietin Proteins 0.000 title claims 27
- 229940105423 erythropoietin Drugs 0.000 title claims 27
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 210000004027 cells Anatomy 0.000 claims 18
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 10
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 9
- 108020004705 Codon Proteins 0.000 claims 7
- 239000001963 growth media Substances 0.000 claims 7
- 239000002609 media Substances 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 150000001720 carbohydrates Chemical class 0.000 claims 4
- 210000004962 mammalian cells Anatomy 0.000 claims 4
- 238000001962 electrophoresis Methods 0.000 claims 3
- 230000002485 urinary Effects 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims 2
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 210000001672 Ovary Anatomy 0.000 claims 1
- 241001631646 Papillomaviridae Species 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 230000001605 fetal Effects 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
Claims (13)
а) культивирование в подходящей среде эукариотических хозяйских клеток, трансформированных последовательностью ДНК, кодирующей эритропоэтин человека, выбранной из группы, состоящей из ДНК, представленной в таблица 3; ДНК, представленной в таблице 4; ДНК, представленной в таблице 4, включающей нуклеотиды "GGТС" 50-членной нуклеотидной последовательности, предшествующей кодону АТG, кодирующему Мet- 27, по нуклеотиды ТGА, следующие за кодоном АGА, кодирующим Агg 166, и ДНК, представленной в Таблице 4, содержащей кодон АТG, кодирующий Меt-27, по нуклеотиды ТGА, следующие за кодоном АGА, кодирующим Агg 166, причем упомянутая последовательность оперативно присоединена к последовательности, контролирующей экспрессию;
b) отделение полученного таким образом эритропоэтина человека от клеток и культуральной среды;
с) приготовление упомянутого эритропоэтина в сочетании с фармацевтически приемлемым носителем.12. A method of obtaining a pharmaceutical composition of human erythropoietin, characterized in that carry out:
a) cultivation in a suitable medium of eukaryotic host cells transformed with a DNA sequence encoding a human erythropoietin selected from the group consisting of the DNA presented in Table 3; DNA presented in table 4; The DNA presented in table 4, including the nucleotides "GGTS" 50-membered nucleotide sequence preceding the ATG codon encoding Met-27, the TGA nucleotides following the AGA coding, encoding AGg 166, and the DNA presented in Table 4 containing the codon ATG encoding Met-27, TGA nucleotides, following the AGA codon encoding Agg 166, and the above sequence operatively attached to the sequence that controls the expression;
b) separating the human erythropoietin thus obtained from the cells and culture medium;
c) preparing said erythropoietin in combination with a pharmaceutically acceptable carrier.
а) культивирование в подходящей среде эукариотических хозяйских клеток, трансформированных последовательностью ДНК, кодирующей эритропоэтин человека, выбранной из группы, состоящей из ДНК, представленной в таблице 3; ДНК, представленной в таблице 4, и ДНК, представленной в таблице 4, содержащей нуклеотиды "GGТС" 50-членной нуклеотидной последовательности, предшествующей кодону АТG, кодирующему Меt-27 по нуклеотиды ТGА, следующие за кодоном АGА, кодирующим Аrg 166, и ДНК, представленной в таблице 4, включающей кодон АТG, кодирующий Меt-27 по нуклеотиды ТGА, следующие за кодоном АGА, кодирующим Аrg 166, причем упомянутые последовательности оперативно присоединены к последовательности, контролирующей экспрессию;
b ) отделение полученного таким образом эритропоэтина человека от клеток и культуральной среды;
с) приготовление упомянутого эритропоэтина в сочетании с фармацевтически приемлемым носителем.13. A method of obtaining a pharmaceutical composition of human erythropoietin, which does not include erythropoietin products having a higher molecular weight, as determined by electrophoresis in SDS-PAG, than erythropoietin isolated from urinary sources, characterized in that they carry out:
a) cultivation in a suitable medium of eukaryotic host cells transformed with a DNA sequence encoding a human erythropoietin selected from the group consisting of the DNA shown in Table 3; The DNA shown in Table 4 and the DNA shown in Table 4 containing the GGTS nucleotides of the 50-membered nucleotide sequence preceding the ATG codon encoding Met-27 for the TGA nucleotides, following the AGA codon encoding AGG 166, and DNA, presented in table 4, including the ATG codon encoding Met-27 for TGA nucleotides, following the AGA codon encoding AGG 166, moreover, these sequences are operatively attached to the expression control sequence;
b) separating the human erythropoietin thus obtained from the cells and culture medium;
c) preparing said erythropoietin in combination with a pharmaceutically acceptable carrier.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US677,813 | 1984-12-04 | ||
US68862285A | 1985-01-03 | 1985-01-03 | |
US688,622 | 1985-01-03 | ||
US693,258 | 1985-01-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96104560A true RU96104560A (en) | 1998-06-27 |
RU2129613C1 RU2129613C1 (en) | 1999-04-27 |
Family
ID=24765108
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU5010104 RU2120996C1 (en) | 1984-12-04 | 1991-11-15 | Dna fragments encoding human erythropoietin, recombinant dnas, cell line, recombinant o-glycosylated human erythropoietin, pharmaceutical composition |
RU96104560A RU2129613C1 (en) | 1985-01-03 | 1996-03-12 | Method of human erythropoietin preparing |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU5010104 RU2120996C1 (en) | 1984-12-04 | 1991-11-15 | Dna fragments encoding human erythropoietin, recombinant dnas, cell line, recombinant o-glycosylated human erythropoietin, pharmaceutical composition |
Country Status (3)
Country | Link |
---|---|
RU (2) | RU2120996C1 (en) |
SK (1) | SK46598A3 (en) |
SU (1) | SU1672930A3 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2523948C1 (en) * | 2013-06-28 | 2014-07-27 | Общество С Ограниченной Ответственностью "Фармапарк" | Eukaryotic host cell for expression of darbepoetin, expression vector and method of production of darbepoetin alfa |
RU2548806C1 (en) * | 2014-01-20 | 2015-04-20 | Общество с ограниченной ответственностью "РД-БИОТЕХ" | Synthetic dna encoding human erythropoietin, comprising its vector, method of production of erythropoietin producer strain, erythropoietin producer strain |
-
1985
- 1985-12-03 SK SK46598A patent/SK46598A3/en unknown
-
1986
- 1986-08-01 SU SU864028136A patent/SU1672930A3/en active
-
1991
- 1991-11-15 RU SU5010104 patent/RU2120996C1/en active
-
1996
- 1996-03-12 RU RU96104560A patent/RU2129613C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fleming et al. | Differentiation in Nostoc muscorum: nitrogenase is synthesized in heterocysts | |
NO874750L (en) | Certain DNA sequences derived from a papilloma virus genome, their use in in vitro diagnostics and production of antigenic preparations. | |
RU2004126135A (en) | NEW CYTOKINE ZALPHA11-LIGAND | |
CA2272046A1 (en) | Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof | |
Kit | Species differences in animal deoxyribonucleic acids as revealed by equilibrium sedimentation in density gradients | |
Grubman et al. | Sub-cellular localization of vesicular stomatitis virus messenger RNAs | |
CN1086543A (en) | Clones coding has the cDNA of people's graininess scavenger cell and eosinophie cellular growth active polypeptide | |
Hooks et al. | Spontaneous transformation of human brain cells grown in vitro and description of associated virus particles | |
FR2602791B1 (en) | METHOD FOR CULTURING TURKEY INFECTIOUS RHINOTRACHEITIS VIRUS, AND VACCINE PREPARED FROM THE VIRUS OBTAINED THEREBY | |
FR2657884B1 (en) | PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS. | |
KR900014428A (en) | New polypeptide and preparation method thereof | |
EP0294469A4 (en) | Vaccines and diagnostic assays for haemophilus influenzae. | |
KR910006483A (en) | Genetic engineering methods using microorganisms of recombinant aprotinin variants, homogeneously processed aprotinin variants, and therapeutic uses thereof | |
AU605155B2 (en) | A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof | |
RU96104560A (en) | METHOD FOR PREPARING HUMAN ERYTHROPOIETIN AND METHOD FOR MAKING A PHARMACEUTICAL COMPOSITION | |
ES8608683A1 (en) | Probe and method for the diagnostic of the sex of a human embryo. | |
EP0432220A4 (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
ES2061850T3 (en) | RECOMBINANT VIRUSES OF MAREK'S DISEASE, ITS PREPARATION PROCEDURE AND VACCINE. | |
Rochford et al. | Establishment of a cell line from embryos of the cabbage looper, Trichoplusia ni (Hubner) | |
GR3015892T3 (en) | Virus resistant plants having a viral coat protein. | |
DK326289A (en) | PROCEDURE FOR MANUFACTURING A PROTEIN FROM YEAR FUNGES USING AN INDUCERABLE SYSTEM, AND VECTORS AND TRANSFORMED STUES FOR USING THE PROCEDURE | |
KR880701285A (en) | Vaccine containing F protein of AIDS virus | |
KR900014599A (en) | Expression Vectors for Protein Synthesis in the Body Yeast Irradiated Caromyces Pombe | |
Nusse et al. | Analysis of secondary modifications of mouse mammary tumor virus proteins by two-dimensional gel electrophoresis | |
George 4th et al. | Identification of a T-cell epitope on the circumsporozoite protein of Plasmodium vivax |